Assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNFα treatment
- 7 December 2004
- Vol. 28 (4-5) , 179-181
- https://doi.org/10.1016/j.cyto.2004.07.013
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapyArthritis & Rheumatism, 2004
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998Thorax, 2001
- Hepatotoxicity Associated With Isoniazid Preventive TherapyJAMA, 1999
- Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998Thorax, 1998
- Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative GroupThorax, 1997
- A Double-blind Placebo-controlled Clinical Trial of Three Antituberculosis Chemoprophylaxis Regimens in Patients with Silicosis in Hong KongAmerican Review of Respiratory Disease, 1992
- Disturbed Hepatic Function during Isoniazid ChemoprophylaxisAmerican Review of Respiratory Disease, 1973